• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-98通过靶向I型胶原蛋白α1链抑制人增生性瘢痕成纤维细胞的增殖。

MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1.

作者信息

Bi Sheng, Chai Linlin, Yuan Xi, Cao Chuan, Li Shirong

机构信息

Department of Plastic and Reconstructive Surgery, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Shapingba District, Chongqing, 400038, China.

出版信息

Biol Res. 2017 Jun 19;50(1):22. doi: 10.1186/s40659-017-0127-6.

DOI:10.1186/s40659-017-0127-6
PMID:28629444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5477152/
Abstract

BACKGROUND

Hypertrophic scarring (HS) is a severe disease, and results from unusual wound healing. Col1A1 could promote the hypertrophic scar formation, and the expression of Col1A1 in HS tissue was markedly higher than that in the normal. In present study, we aimed to identify miRNAs as post-transcriptional regulators of Col1A1 in HS.

METHODS

MicroRNA-98 was selected as the key miRNA comprised in HS. The mRNA levels of miR-98 in HS tissues and the matched normal skin tissues were determined by qRT-PCR. MTT and flow cytometry were used to determine the influence of miR-98 on cell proliferation and apoptosis of HSFBs, respectively. Col1A1 was found to be the target gene of miR-98 using luciferase reporter assay. Luciferase assay was performed to determine the relative luciferase activity in mimic NC, miR-98 mimic, inhibitor NC and miR-98 inhibitor with Col1A13'-UTR wt or Col1A13'-UTR mt reporter plasmids. The protein expression of Col1A1 in HSFBs after transfection with mimic NC, miR-98 mimic, inhibitor NC and miR-98 inhibitor were determined by western blotting.

RESULTS

The mRNA level of miR-98 in HS tissues was much higher than that in the control. Transfection of HSFBs with a miR-98 mimic reduced the cell viability of HSFBs and increased the apoptosis portion of HSFBs, while inhibition of miR-98 increased cell viability and decreased apoptosis portion of HSFBs. miR-98 inhibitor increased the relative luciferase activity significantly when cotransfected with the Col1A1-UTR reporter plasmid, while the mutant reporter plasmid abolished the miR-98 inhibitor-mediated increase in luciferase activity. Western blotting revealed that overexpression of miR-98 decreased the expression of Col1A1.

CONCLUSIONS

Overexpression of miR-98 repressed the proliferation of HSFBs by targeting Col1A1.

摘要

背景

肥厚性瘢痕(HS)是一种严重疾病,由异常伤口愈合导致。Ⅰ型胶原蛋白α1(Col1A1)可促进肥厚性瘢痕形成,且HS组织中Col1A1的表达明显高于正常组织。在本研究中,我们旨在鉴定作为HS中Col1A1转录后调节因子的微小RNA(miRNA)。

方法

选择微小RNA-98(miR-98)作为HS中的关键miRNA。通过定量逆转录聚合酶链反应(qRT-PCR)测定HS组织及配对的正常皮肤组织中miR-98的信使核糖核酸(mRNA)水平。分别使用噻唑蓝(MTT)法和流式细胞术测定miR-98对人肥厚性瘢痕成纤维细胞(HSFBs)细胞增殖和凋亡的影响。使用荧光素酶报告基因检测法发现Col1A1是miR-98的靶基因。进行荧光素酶检测以确定在模拟对照(mimic NC)、miR-98模拟物、抑制剂对照(inhibitor NC)和miR-98抑制剂与野生型Col1A1 3'-非翻译区(Col1A1 3'-UTR wt)或突变型Col1A1 3'-非翻译区(Col1A1 3'-UTR mt)报告质粒共转染时的相对荧光素酶活性。通过蛋白质免疫印迹法测定在转染模拟对照、miR-98模拟物、抑制剂对照和miR-98抑制剂后HSFBs中Col1A1的蛋白表达。

结果

HS组织中miR-98的mRNA水平远高于对照组。用miR-98模拟物转染HSFBs降低了HSFBs的细胞活力并增加了HSFBs的凋亡比例,而抑制miR-98则增加了细胞活力并降低了HSFBs的凋亡比例。当与Col1A1-UTR报告质粒共转染时,miR-98抑制剂显著增加了相对荧光素酶活性,而突变型报告质粒消除了miR-98抑制剂介导的荧光素酶活性增加。蛋白质免疫印迹法显示miR-98的过表达降低了Col1A1的表达。

结论

miR-98的过表达通过靶向Col1A1抑制HSFBs的增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/d2a6f77baa1c/40659_2017_127_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/b83920bdcf94/40659_2017_127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/8ba7c08acb1e/40659_2017_127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/27fb519ef626/40659_2017_127_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/d2a6f77baa1c/40659_2017_127_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/b83920bdcf94/40659_2017_127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/8ba7c08acb1e/40659_2017_127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/27fb519ef626/40659_2017_127_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0752/5477152/d2a6f77baa1c/40659_2017_127_Fig4_HTML.jpg

相似文献

1
MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1.微小RNA-98通过靶向I型胶原蛋白α1链抑制人增生性瘢痕成纤维细胞的增殖。
Biol Res. 2017 Jun 19;50(1):22. doi: 10.1186/s40659-017-0127-6.
2
Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism.Hsa-miR-31-5p在增生性瘢痕形成中的作用及机制研究
Exp Cell Res. 2017 Dec 15;361(2):201-209. doi: 10.1016/j.yexcr.2017.09.009. Epub 2017 Oct 19.
3
MiR-6836-3p promotes proliferation of hypertrophic scar fibroblasts by targeting CTGF.miR-6836-3p 通过靶向 CTGF 促进增生性瘢痕成纤维细胞的增殖。
Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4069-4074. doi: 10.26355/eurrev_201807_15396.
4
MicroRNA-9-5p inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting peroxisome proliferator-activated receptor β.miR-9-5p 通过靶向过氧化物酶体增殖物激活受体 β 抑制人增生性瘢痕成纤维细胞的增殖并诱导其凋亡。
Biol Open. 2020 Dec 21;9(12):bio051904. doi: 10.1242/bio.051904.
5
MiR-486-5p inhibits the hyperproliferation and production of collagen in hypertrophic scar fibroblasts IGF1/PI3K/AKT pathway.miR-486-5p 通过 IGF1/PI3K/AKT 通路抑制增生性瘢痕成纤维细胞的过度增殖和胶原产生。
J Dermatolog Treat. 2021 Dec;32(8):973-982. doi: 10.1080/09546634.2020.1728210. Epub 2020 Feb 21.
6
[Expression and effect of microRNA-627 in human hypertrophic scar].微小RNA-627在人增生性瘢痕中的表达及作用
Zhonghua Shao Shang Za Zhi. 2021 Apr 20;37(4):369-376. doi: 10.3760/cma.j.cn501120-20200225-00090.
7
Blocking the MIR155HG/miR-155 axis reduces CTGF-induced inflammatory cytokine production and α-SMA expression via upregulating AZGP1 in hypertrophic scar fibroblasts.阻断 MIR155HG/miR-155 轴通过上调增殖细胞核抗原在肥厚性瘢痕成纤维细胞中减少 CTGF 诱导的炎症细胞因子产生和 α-SMA 表达。
Cell Signal. 2024 Aug;120:111202. doi: 10.1016/j.cellsig.2024.111202. Epub 2024 May 9.
8
[microRNA-222 regulates proliferation and apoptosis of fibroblasts in hypertrophic scar via matrix metalloproteinase 1].[微小RNA-222通过基质金属蛋白酶1调节增生性瘢痕中成纤维细胞的增殖和凋亡]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 May 25;46(6):609-617. doi: 10.3785/j.issn.1008-9292.2017.12.06.
9
miR-124-3p targeting of TGF-β1 inhibits the proliferation of hypertrophic scar fibroblasts.miR-124-3p 靶向 TGF-β1 抑制增生性瘢痕成纤维细胞的增殖。
Adv Clin Exp Med. 2021 Mar;30(3):263-271. doi: 10.17219/acem/131753.
10
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145.过氧化物酶体增殖物激活受体γ(PPAR-γ)激动剂通过miR-145靶向Smad3抑制人增生性瘢痕成纤维细胞中的胶原蛋白合成。
Biochem Biophys Res Commun. 2015 Mar 27;459(1):49-53. doi: 10.1016/j.bbrc.2015.02.061. Epub 2015 Feb 20.

引用本文的文献

1
Elucidating the dual roles of apoptosis and necroptosis in diabetic wound healing: implications for therapeutic intervention.阐明细胞凋亡和坏死性凋亡在糖尿病伤口愈合中的双重作用:对治疗干预的启示。
Burns Trauma. 2025 Jan 22;13:tkae061. doi: 10.1093/burnst/tkae061. eCollection 2025.
2
Deciphering Collagen Phenotype Dynamics Regulators: Insights from In-Silico Analysis.解析胶原蛋白表型动力学调节剂:来自计算机模拟分析的见解
J Bioinform Syst Biol. 2024;7(3):169-181. doi: 10.26502/jbsb.5107089. Epub 2024 Sep 19.
3
Efficacy of MSC-derived small extracellular vesicles in treating type II diabetic cutaneous wounds: a systematic review and meta-analysis of animal models.

本文引用的文献

1
MicroRNA‑185 regulates transforming growth factor‑β1 and collagen‑1 in hypertrophic scar fibroblasts.微小RNA-185调节增生性瘢痕成纤维细胞中的转化生长因子-β1和胶原蛋白-1。
Mol Med Rep. 2017 Apr;15(4):1489-1496. doi: 10.3892/mmr.2017.6179. Epub 2017 Feb 8.
2
Genetic association of the COL1A1 gene promoter -1997 G/T (rs1107946) andSp1 +1245 G/T (rs1800012) polymorphisms and keloid scars in a Jeddah population.COL1A1 基因启动子-1997 G/T(rs1107946)和 Sp1+1245 G/T(rs1800012)多态性与吉达人群瘢痕疙瘩的遗传关联。
Turk J Med Sci. 2016 Feb 17;46(2):414-23. doi: 10.3906/sag-1412-41.
3
miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
MSC 来源的小细胞外囊泡治疗 II 型糖尿病皮肤创面的疗效:动物模型的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Jul 15;15:1375632. doi: 10.3389/fendo.2024.1375632. eCollection 2024.
4
Let-7 family regulates HaCaT cell proliferation and apoptosis via the ΔNp63/PI3K/AKT pathway.Let-7家族通过ΔNp63/PI3K/AKT信号通路调控HaCaT细胞的增殖和凋亡。
Open Med (Wars). 2024 Mar 23;19(1):20240925. doi: 10.1515/med-2024-0925. eCollection 2024.
5
Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers.理解糖尿病足溃疡中的分子机制和 miRNA 靶标。
Mol Biol Rep. 2024 Jan 6;51(1):82. doi: 10.1007/s11033-023-09074-0.
6
Reviewing the Regulators of COL1A1.探讨 COL1A1 的调控因子。
Int J Mol Sci. 2023 Jun 11;24(12):10004. doi: 10.3390/ijms241210004.
7
Mechanisms underlying pathological scarring by fibroblasts during wound healing.成纤维细胞在伤口愈合过程中病理性瘢痕形成的机制。
Int Wound J. 2023 Aug;20(6):2190-2206. doi: 10.1111/iwj.14097. Epub 2023 Feb 1.
8
LncRNA FPASL suppresses fibroblast proliferation through its DNA methylation via DNMT3b in hypertrophic scar.长链非编码 RNA FPASL 通过 DNMT3b 介导的 DNA 甲基化抑制增生性瘢痕成纤维细胞增殖。
Acta Biochim Biophys Sin (Shanghai). 2022 Dec 25;54(12):1-9. doi: 10.3724/abbs.2022181.
9
Is the future scarless? - Fibroblasts as targets for scarless wound healing: a narrative review.未来会无疤吗?——成纤维细胞作为无疤伤口愈合的靶点:一篇综述
Scars Burn Heal. 2022 Sep 1;8:20595131221095348. doi: 10.1177/20595131221095348. eCollection 2022 Jan-Dec.
10
Knockdown of lncRNA-NEAT1 expression inhibits hypoxia-induced scar fibroblast proliferation through regulation of the miR-488-3p/COL3A1 axis.lncRNA-NEAT1表达的敲低通过调节miR-488-3p/COL3A1轴抑制缺氧诱导的瘢痕成纤维细胞增殖。
Exp Ther Med. 2022 May 13;24(1):442. doi: 10.3892/etm.2022.11369. eCollection 2022 Jul.
微小RNA-145通过诱导肌成纤维细胞活性促进皮肤肥厚性瘢痕形成。
Mol Med. 2015 Apr 9;21(1):296-304. doi: 10.2119/molmed.2014.00172.
4
MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA.微小RNA-10a和微小RNA-181c通过靶向纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物来调节增生性瘢痕中I型胶原蛋白的生成。
FEBS Lett. 2015 Jan 30;589(3):380-9. doi: 10.1016/j.febslet.2014.12.024. Epub 2014 Dec 29.
5
Targeting Inflammatory Cytokines and Extracellular Matrix Composition to Promote Wound Regeneration.靶向炎症细胞因子和细胞外基质组成以促进伤口再生。
Adv Wound Care (New Rochelle). 2014 Apr 1;3(4):344-355. doi: 10.1089/wound.2013.0456.
6
Over-expression of miR-98 in FFPE tissues might serve as a valuable source for biomarker discovery in breast cancer patients.福尔马林固定石蜡包埋(FFPE)组织中miR-98的过表达可能是乳腺癌患者生物标志物发现的宝贵来源。
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1166-71. eCollection 2014.
7
Resveratrol-mediated reduction of collagen by inhibiting proliferation and producing apoptosis in human hypertrophic scar fibroblasts.白藜芦醇通过抑制人增生性瘢痕成纤维细胞的增殖并诱导其凋亡来减少胶原蛋白。
Biosci Biotechnol Biochem. 2013;77(12):2389-96. doi: 10.1271/bbb.130502. Epub 2013 Dec 7.
8
Pressure therapy upregulates matrix metalloproteinase expression and downregulates collagen expression in hypertrophic scar tissue.压力疗法可上调增生性瘢痕组织中基质金属蛋白酶的表达,下调胶原的表达。
Chin Med J (Engl). 2013;126(17):3321-4.
9
MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.MicroRNA-98 通过靶向胰岛素样生长因子 1 诱导类似阿尔茨海默病的紊乱。
Neurosci Bull. 2013 Dec;29(6):745-51. doi: 10.1007/s12264-013-1348-5. Epub 2013 Jun 5.
10
The molecular mechanism of hypertrophic scar.增生性瘢痕的分子机制。
J Cell Commun Signal. 2013 Dec;7(4):239-52. doi: 10.1007/s12079-013-0195-5. Epub 2013 Mar 18.